ABSTRACT
BACKGROUND: When waiting times for new and return patient visits at Hershey Medical Center's Department of Dermatology approached 4 and 2 months, respectively, the Hershey access clinic was implemented to increase access for patients with acute problems. OBJECTIVE: The purpose of this study was to assess the impact of the Hershey access clinic on patient care. RESULTS: The great majority of patients were satisfied with the access clinic. However, there has been no effect on the no-show rates or patient waiting times for routine appointments. Fifty-seven percent of patients had eruptions, most commonly acne/rosacea, and 43% had neoplasms, most commonly warts. LIMITATIONS: This study was limited by the fact that it was a survey filled out by the patients after their encounter. CONCLUSION: The Hershey access clinic successfully provides acute problem-focused care, and patient satisfaction is high.
Subject(s)
Dermatology/organization & administration , Health Services Accessibility , Models, Organizational , Outpatient Clinics, Hospital/organization & administration , Skin Diseases , Waiting Lists , Acute Disease , Appointments and Schedules , Health Care Surveys , Humans , Patient Satisfaction , Pennsylvania , Skin Diseases/diagnosis , Skin Diseases/therapyABSTRACT
BACKGROUND: Individuals at increased risk of melanoma should use sun-protective measures to decrease their risk of developing melanoma. OBSERVATION: We report a case of a 39-year-old patient with a CDKN2A mutation who developed 3 primary melanomas within a few years of initiating tanning bed use. CONCLUSION: Intense UV exposure as an adult likely contributed to the development of additional primary melanomas in this individual.
Subject(s)
Beauty Culture , Cyclin-Dependent Kinase Inhibitor p16/genetics , Melanoma/diagnosis , Skin Neoplasms/diagnosis , Ultraviolet Rays/adverse effects , Abdomen , Adult , Diagnosis, Differential , Humans , Leg , Male , Melanoma/etiology , Melanoma/genetics , Mutation , Risk Factors , Shoulder , Skin Neoplasms/etiology , Skin Neoplasms/geneticsABSTRACT
Infliximab infusion is not yet FDA-approved for psoriasis but has been reported to be very effective for plaque psoriasis. We report 2 patients without a history of psoriasis who after administration of infliximab for their inflammatory bowel disease experienced new onset, biopsy confirmed psoriasis.
Subject(s)
Antibodies, Monoclonal/adverse effects , Dermatologic Agents/adverse effects , Psoriasis/chemically induced , Adult , Humans , Inflammatory Bowel Diseases/drug therapy , Infliximab , MaleABSTRACT
Basal cell carcinoma (BCC) has many histologic variants. These variants may show differentiation toward benign and malignant tumors of cutaneous appendages, especially hair follicles. Herein we describe a lesion that was clinically thought to be a BCC, but a superficial biopsy showed histologic features suggestive of an apocrine hidrocystoma. Because of some cytologic atypia, complete excision was recommended. The excision specimen revealed a cystic BCC. The importance of examining the entire neoplasm before reaching a final pathologic diagnosis is emphasized.
